Cardiology
Stable Angina Assessment and Management
Diagnosis, medical management, and revascularisation decision-making for stable angina.
Source: NICE NG185; ESC 2019 Chronic Coronary Syndromes Guidelines
Step 1 of ~7
action
History and Risk Factor Assessment
Typical stable angina characteristics:
• Central chest tightness/heaviness
• Precipitated by exertion or emotional stress
• Relieved by rest or GTN within 5 minutes
Typical = all 3 features. Atypical = 2 features. Non-cardiac = 0–1 features.
Risk factors: diabetes, hypertension, hyperlipidaemia, smoking, family history of premature CAD, obesity, sedentary lifestyle.
Examination: BP (both arms), signs of aortic stenosis, peripheral vascular disease, BMI, xanthelasmata.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Isosorbide Mononitrate (Stable Angina) · Nitrate / Stable Angina
- Nicorandil · Stable Angina
- Ranolazine · Refractory Stable Angina
- Silicone Gel / Sheeting (Scar Management) · Medical Device / Topical Scar Treatment
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only. Always apply local guidelines and clinical judgement.